Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Recapitulate the Predilection of Breast Cancer Patients to Doxorubicin–Induced Cardiotoxicity

Doxorubicin (Adriamycin) is an anthracycline chemotherapy agent effective in treating a wide range of malignancies with a well–established dose–response cardiotoxic side effect that can lead to heart failure. At present, it is not possible to predict which patients will be affected by doxorubicin-in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nat Med
Autores principales: Burridge, Paul W., Li, Yong Fuga, Matsa, Elena, Wu, Haodi, Ong, Sang–Ging, Sharma, Arun, Holmström, Alexandra, Chang, Alex C., Coronado, Michael J., Ebert, Antje D., Knowles, Joshua W., Telli, Melinda L., Witteles, Ronald M., Blau, Helen M., Bernstein, Daniel, Altman, Russ B., Wu, Joseph C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086256/
https://ncbi.nlm.nih.gov/pubmed/27089514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4087
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares